MeMeds COVID-19 Severity Test erhält die CE-Kennzeichnung für die Vorhersage von schwerwiegenden Krankheitsverläufen bei COVID-19-Patienten*innen
27 juil. 2021 02h00 HE
|
MeMed
MeMeds COVID-19 Severity Test erhält die CE-Kennzeichnung für die Vorhersage von schwerwiegenden Krankheitsverläufen bei COVID-19-Patienten*innenDer MeMed COVID-19 Severity™ Test analysiert das...
MeMed Key® Wins Red Dot Award for High Design Quality
22 avr. 2021 07h00 HE
|
MeMed
MeMed Key® Wins Red Dot Award for High Design Quality HAIFA, April 22, 2021- frog, a leading global design and strategy consultancy, part of...
MeMed and 360Dx Bring Together International Experts for a Timely Discussion on Predicting COVID-19 Severity Using the Host Immune Response
13 avr. 2021 07h00 HE
|
MeMed
MeMed and 360Dx Bring Together International Experts for a Timely Discussion on Predicting COVID-19 Severity Using the Host Immune Response HAIFA, Israel, April 13, 2021 – MeMed, a leader in...
Troy Boutelle Joins MeMed as Vice President of Commercial in North America and General Manager, U.S.
12 janv. 2021 07h00 HE
|
MeMed
Troy Boutelle Joins MeMed as Vice President of Commercial in North America and General Manager, U.S. Troy brings 20 years of top-flight sales and commercial experience as MeMed expands into the U.S....
MeMed Appoints Industry Veteran Chris Hibberd to its Board of Directors
16 déc. 2020 07h12 HE
|
MeMed
MeMed Appoints Industry Veteran Chris Hibberd to its Board of Directors HAIFA, Israel, December 16, 2020 – MeMed, a leader in host immune response-based solutions, today announced that Chris Hibberd...
MeMed Selected to Present at BARDA Industry Day 2020
26 oct. 2020 07h00 HE
|
MeMed
MeMed Selected to Present at BARDA Industry Day 2020 Dr. Eran Eden to Give Lightning Talk on October 27 on MeMed’s Advanced Host-Immune Response Technology HAIFA, Israel, October 26, 2020 – MeMed™,...
DiaSorin and MeMed partner to develop and commercialize novel host immune response based diagnostics solution
08 sept. 2020 07h00 HE
|
MeMed
DiaSorin and MeMed partner to develop and commercialize novel host immune response based diagnostics solution ...
DiaSorin 与 MeMed 合作开发和商业化基于新型宿主免疫应答的诊断解决方案
08 sept. 2020 02h02 HE
|
MeMed
DiaSorin 与 MeMed 合作开发和商业化基于新型宿主免疫应答的诊断解决方案 ...
DiaSorin and MeMed partner to develop and commercialize novel host immune response based diagnostics solution
08 sept. 2020 01h30 HE
|
MeMed
DiaSorin and MeMed partner to develop and commercialize novel host immune response based diagnostics solution ...
הישראלית חתמו על MeMed-ו DiaSorin שיתוף פעולה אסטרטגי
08 sept. 2020 01h30 HE
|
MeMed
הודעה לעיתונות הישראלית חתמו על MeMed-ו DiaSorin שיתוף פעולה אסטרטגי הבדיקה שפיתחה MeMed, המבחינה בין זיהומים ויראלים לחיידקיים במהירות ובדיוק רב, תשולב בתפריט פלטפורמת הבדיקות של החברה...